{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:58:36Z","timestamp":1761101916457},"reference-count":89,"publisher":"Elsevier BV","issue":"21-22","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.cca.2010.06.024","type":"journal-article","created":{"date-parts":[[2010,7,2]],"date-time":"2010-07-02T08:23:38Z","timestamp":1278059018000},"page":"1547-1552","source":"Crossref","is-referenced-by-count":29,"title":["Screening for adverse pregnancy outcome at early gestational age"],"prefix":"10.1016","volume":"411","author":[{"given":"Sophie","family":"Hourrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent J.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Dreux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2010.06.024_bb0005","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0378-3782(96)01814-2","article-title":"Established markers in second trimester maternal serum","volume":"47 Suppl","author":"Cuckle","year":"1996","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.cca.2010.06.024_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0028-2243(95)02293-2","article-title":"Maternal serum markers for fetal trisomy 21 screening","volume":"65","author":"Muller","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.cca.2010.06.024_bb0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1469-0705.1999.13040231.x","article-title":"A screening program for trisomy 21 at 10\u201314weeks using fetal nuchal translucency, maternal serum free \u03b2-human chorionic gonadotropin and pregnancy associated plasma protein-A","volume":"13","author":"Spencer","year":"1999","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0301-2115(00)00431-0","article-title":"Biochemical screening for Down syndrome","volume":"92","author":"Cuckle","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.cca.2010.06.024_bb0025","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0002-9378(85)90385-0","article-title":"A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome","volume":"151","author":"Benacerraf","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9378(95)90008-X","article-title":"Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography","volume":"172","author":"Vintzileos","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1469-0705.1998.12010008.x","article-title":"Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases","volume":"12","author":"Nyberg","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0040","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1148\/radiology.215.3.r00ma36775","article-title":"The \u201cgenetic sonogram\u201d: comparison of the index scoring system with the age-adjusted US risk assessment","volume":"215","author":"Winter","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.cca.2010.06.024_bb0045","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7863\/jum.2001.20.6.655","article-title":"Sonographic markers of fetal trisomies: second trimester","volume":"20","author":"Nyberg","year":"2001","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.cca.2010.06.024_bb0050","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7863\/jum.2002.21.10.1087","article-title":"The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester","volume":"21","author":"Bromley","year":"2002","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.cca.2010.06.024_bb0055","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mob.2002.121651","article-title":"The comprehensive midtrimester test: high-sensitivity Down syndrome test","volume":"186","author":"Bahado-Singh","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajog.2004.08.036","article-title":"Mid trimester sonographic findings for the prediction of Down syndrome in a sonographically screened population","volume":"192","author":"Schluter","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0065","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/(SICI)1097-0223(199911)19:11<1035::AID-PD694>3.0.CO;2-2","article-title":"Screening for trisomy 18 by fetal nuchal translucency and maternal serum free \u03b2-hCG and pregnancy associated plasma protein-A at 10\u201314weeks of gestation","volume":"19","author":"Tul","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/(SICI)1097-0223(200005)20:5<411::AID-PD822>3.0.CO;2-2","article-title":"Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta hCG and pregnancy associated plasma protein A at 10\u201314weeks of gestation","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1097-0223(200006)20:6<495::AID-PD846>3.0.CO;2-U","article-title":"Screening for triploidy by fetal nuchal translucency and maternal serum free \u03b2 Human chorionic gonadotropin and pregnancy associated plasma protein-A at 10\u201314 weeks of gestation","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1471-0528.2003.02246.x","article-title":"Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience","volume":"110","author":"Spencer","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.cca.2010.06.024_bb0085","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.ajog.2005.03.021","article-title":"Prospective first-trimester screening for trisomy 21 in 30, 564 pregnancies","volume":"192","author":"Avgidou","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/uog.1860","article-title":"Multitcenter study of first-trimester screening for trisomy 21 in 75, 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening","volume":"25","author":"Nicolaides","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0095","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0895-4356(94)90126-0","article-title":"Preferences of pregnant women for amniocentesis or chorionic villus sampling for prenatal testing: comparison of patients' choices and those of a decision-analytic model","volume":"47","author":"Heckerling","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cca.2010.06.024_bb0100","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1100\/tsw.2003.81","article-title":"Late termination of pregnancy. Professional dilemmas","volume":"3","author":"Kandel","year":"2003","journal-title":"Sci World J"},{"key":"10.1016\/j.cca.2010.06.024_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/uog.7526","article-title":"Prima facie","volume":"35","author":"Ville","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/uog.7552","article-title":"From nuchal translucency to intracranial translucency: towards the early detection of spina bifida","volume":"35","author":"Chaoui","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajog.2004.03.090","article-title":"Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities","volume":"191","author":"Nicolaides","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0120","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/uog.6371","article-title":"The impact of crown rump length measurement error on combined Down syndrome screening: a simulation study","volume":"33","author":"Salomon","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(97)11280-6","article-title":"UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10\u201314weeks of gestation","volume":"352","author":"Snijders","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2010.06.024_bb0130","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ajog.2004.12.093","article-title":"Increased nuchal translucency with normal karyotype","volume":"192","author":"Souka","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0135","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1067\/S0002-9378(03)00645-8","article-title":"Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis","volume":"189","author":"Makrydimas","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1469-0705.1998.11060391.x","article-title":"Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency at 10\u201314weeks of gestation","volume":"11","author":"Souka","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1469-0705.2001.00454.x","article-title":"Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester","volume":"18","author":"Souka","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1469-0705.2001.00341.x","article-title":"Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses","volume":"17","author":"Michailidis","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajmg.c.30119","article-title":"Aneuploidy screening in the first trimester","volume":"145c","author":"Spencer","year":"2007","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.cca.2010.06.024_bb0160","series-title":"Prenatal diagnosis and screening","first-page":"351","article-title":"Prevalence, risks and recurrence","author":"Hook","year":"1992"},{"key":"10.1016\/j.cca.2010.06.024_bb0165","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0029-7844(00)01044-9","article-title":"Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997","volume":"96","author":"Egan","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000264259","article-title":"Maternal age and gestational age specific risks for chromosomal defects","volume":"10","author":"Snijders","year":"1995","journal-title":"Fetal Diag Ther"},{"key":"10.1016\/j.cca.2010.06.024_bb0175","series-title":"Principles and practice of medical genetics","first-page":"763","article-title":"Prenatal screening for neural tube defects and aneuploidy","author":"Aitken","year":"2002"},{"key":"10.1016\/j.cca.2010.06.024_bb0180","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/pd.2395","article-title":"Maternal serum screening marker levels in women with a previous aneuploidy pregnancy","volume":"29","author":"Spencer","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0185","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/pd.438","article-title":"Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854, 902 patients","volume":"22","author":"Muller","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1469-0705.2002.00808.x","article-title":"One-stop clinic for assessment of risk for trisomy 21 at 11\u201314weeks: a prospective study of 15 030 pregnancies","volume":"20","author":"Bindra","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0195","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/uog.5331","article-title":"Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A","volume":"31","author":"Kagan","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0200","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/uog.1775","article-title":"Assessment of fetal anatomy at the 11\u201314-week ultrasound examination","volume":"24","author":"Souka","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0205","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/pd.2247","article-title":"First-trimester Down syndrome screening performance in the Dutch population; how to achieve further improvement?","volume":"29","author":"Wortelboer","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0210","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMoa025273","article-title":"First-trimester screening for trisomies 21 and 18","volume":"349","author":"Wapner","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2010.06.024_bb0215","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(03)12680-3","article-title":"Antenatal screening for Down's syndrome with the quadruple test","volume":"361","author":"Wald","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2010.06.024_bb0220","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down's syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2010.06.024_bb0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1258\/096914103321824133","article-title":"First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)","volume":"10","author":"Wald","year":"2003","journal-title":"J Med Screen"},{"key":"10.1016\/j.cca.2010.06.024_bb0230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/GCO.0b013e3280895e00","article-title":"Screening for aneuploidy in first- and second-trimester: is there an optimal paradigm?","volume":"19","author":"Breathnach","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0235","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/pd.974","article-title":"Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening","volume":"24","author":"Wright","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0240","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.semperi.2005.05.004","article-title":"Down syndrome screening in the first and\/or second trimester: model predicted performance using meta-analysis parameters","volume":"29","author":"Cuckle","year":"2005","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.cca.2010.06.024_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.AOG.0000263470.89007.e3","article-title":"First- and second-trimester evaluation of risk for Down syndrome","volume":"110","author":"Ball","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0250","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/GRF.0b013e31804c9b99","article-title":"Comparison of first and second trimester aneuploidy risk assessment","volume":"50","author":"Reddy","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0255","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/pd.1498","article-title":"Sequential and contingent prenatal screening for Down syndrome","volume":"26","author":"Wald","year":"2006","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0260","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.AOG.0000195061.48747.f4","article-title":"Comparing three screening strategies for combining first- and second-trimester Down syndrome markers","volume":"107","author":"Palomaki","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0265","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/uog.6330","article-title":"Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11\u201313weeks of gestation","volume":"33","author":"Maiz","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0270","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.6264","article-title":"Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6weeks of gestation","volume":"33","author":"Kagan","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0275","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/(SICI)1097-0223(200005)20:5<390::AID-PD824>3.0.CO;2-B","article-title":"Maternal serum free beta-hCG and PAPP-A in fetal sex chromosome defects in the first trimester","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/1096-8628(20010722)102:1<73::AID-AJMG1419>3.0.CO;2-H","article-title":"Ultrasonographic and clinical appearance of a 22-week-old fetus with Brachmann-de Lange syndrome","volume":"102","author":"Urban","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.cca.2010.06.024_bb0285","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0029-7844(02)01982-8","article-title":"Abnormal first-trimester fetal nuchal translucency and Cornelia De Lange syndrome","volume":"99","author":"Huang","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0290","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/(SICI)1097-0223(199908)19:8<706::AID-PD613>3.0.CO;2-W","article-title":"Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies","volume":"19","author":"Aitken","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0295","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/pd.690","article-title":"Low first-trimester pregnancy-associated plasma protein-A and Cornelia de Lange syndrome","volume":"23","author":"Arbuzova","year":"2003","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0300","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/pd.1923","article-title":"Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0305","series-title":"Multiple pregnancy","first-page":"56","article-title":"Prenatal determination of chorionicity and zygosity","author":"Fisk","year":"1995"},{"key":"10.1016\/j.cca.2010.06.024_bb0310","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/pd.2445","article-title":"First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers","volume":"30","author":"Spencer","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0315","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1471-0528.2003.02222.x","article-title":"Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience","volume":"110","author":"Spencer","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.cca.2010.06.024_bb0320","doi-asserted-by":"crossref","first-page":"b138","DOI":"10.1136\/bmj.b138","article-title":"Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation","volume":"338","author":"Gekas","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2010.06.024_bb0325","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/pd.701","article-title":"Do women prefer to have screening tests for Down syndrome that have the lowest screen-positive rate or the highest detection rate?","volume":"23","author":"Mulvey","year":"2003","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/uog.1768","article-title":"Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies","volume":"24","author":"Spencer","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0335","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ajog.2005.02.134","article-title":"Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21","volume":"193","author":"Nicolaides","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0340","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2010.06.024_bb0345","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-0528.2000.tb11618.x","article-title":"First trimester maternal serum free human chorionic gonadotropin and pregnancy associated plasma protein A as predictors of pregnancy complications","volume":"107","author":"Ong","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.cca.2010.06.024_bb0350","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000065384","article-title":"First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome","volume":"17","author":"Yaron","year":"2002","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.cca.2010.06.024_bb0355","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000191302.79560.d8","article-title":"Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome","volume":"107","author":"Smith","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0360","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","article-title":"First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)","volume":"191","author":"Dugoff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0365","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/pd.2116","article-title":"Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0370","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/pd.1997","article-title":"Down syndrome biochemical markers and screening for pre-eclampsia at first and second trimester: correlation with the week of onset and the severity","volume":"28","author":"Kang","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0375","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/uog.5165","article-title":"First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses","volume":"31","author":"Spencer","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0380","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.AOG.0000129969.78308.4f","article-title":"Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss","volume":"104","author":"Goetzl","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0385","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/pd.600","article-title":"Frequency and clinical consequences of extremely high maternal serum PAPP-A levels","volume":"23","author":"Cuckle","year":"2003","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0390","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/pd.735","article-title":"Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A","volume":"23","author":"Tul","year":"2003","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0395","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bpobgyn.2004.02.003","article-title":"The role of uterine artery Doppler in predicting adverse pregnancy outcome","volume":"18","author":"Papageorghiou","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0400","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/pd.1251","article-title":"Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler","volume":"25","author":"Spencer","year":"2005","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0405","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/pd.2440","article-title":"Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11\u201313weeks","volume":"30","author":"Poon","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0410","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/uog.2686","article-title":"A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound","volume":"27","author":"Nicolaides","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0415","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ajog.2004.05.068","article-title":"Association of extreme first-trimester free human chorionic gonadotropin-b, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes","volume":"191","author":"Krantz","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0420","doi-asserted-by":"crossref","first-page":"412.e1-6","DOI":"10.1016\/j.ajog.2009.07.016","article-title":"The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders","volume":"201","author":"Goetzinger","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0425","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/uog.3809","article-title":"First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death","volume":"28","author":"Spencer","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cca.2010.06.024_bb0430","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000095843","article-title":"First trimester Down's syndrome screening shows high detection rate for trisomy 21, but poor performance in structural abnormalities\u2014regional outcome results","volume":"22","author":"Rissanen","year":"2007","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.cca.2010.06.024_bb0435","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/(SICI)1097-0223(199908)19:8<788::AID-PD609>3.0.CO;2-Q","article-title":"Low maternal serum PAPP-A and fetal viability","volume":"19","author":"Cuckle","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cca.2010.06.024_bb0440","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.292.18.2249","article-title":"First-trimester placentation and the risk of antepartum stillbirth","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2010.06.024_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.2005.00575.x","article-title":"The epidemiology of preterm labour","volume":"112","author":"Steer","year":"2005","journal-title":"BJOG"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110004328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110004328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T15:21:08Z","timestamp":1635607268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898110004328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":89,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0009898110004328"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2010.06.024","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}